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Introduction
Point of care ultrasound (POCUS) can be a
useful bedside tool in deciding whether
diagnostic thoracentesis is warranted in patients
presenting with pleural effusion. Patients with a
clinical history suggesting transudative etiology
of a pleural effusion may not require
thoracentesis. However, certain sonographic
characteristics of pleural effusions are strongly
associated with exudative processes and may
indicate thoracentesis regardless of clinical
history. Specifically, complex septated
appearance of pleural fluid has a positive
likelihood ratio of 7.33 for exudative processes
[1] and pleural thickness >1cm has a positive
likelihood ratio of 8.4 for malignant pleural
effusion [2]. In addition, an echogenic swirling
pattern suggests malignant pleural effusion, but
has limited positive likelihood ratio of 2.96 [3, 4].
Notably, echogenicity alone appears to correlate
poorly to whether an effusion is transudative,
exudative, or malignant and should not
significantly influence clinical decision making [5].
Here we present an interesting case of a mixedetiology pleural effusion whose clinical course
was significantly altered after sonographic signs
of malignant pleural effusion were identified
using POCUS.
Case
An 87-year-old-woman with history of congestive
heart failure (CHF) and previously-diagnosed 1
cm pancreatic head mass was admitted for acute
hypoxemic respiratory failure in the setting of
volume overload and bilateral pleural effusions
following several weeks of non-compliance with
her outpatient diuretic regimen. Given a clear
clinical explanation for a transudative CHFprocess driving her pleural effusion a diagnostic
thoracentesis was not initially performed. Within
48 hours of IV diuresis the patient was no longer
requiring supplemental oxygen and expressed

Case continued...
expressed to the internal medicine team that she
was eager to return home. However, during
POCUS teaching rounds prior to discharge she
was incidentally found to have an echogenic
pleural effusion with fibrinous-appearing
septations and pleural thickness of approximately
1 cm. Due to these findings and patient’s history
of pancreatic head mass a diagnostic
thoracentesis was ordered. Pleural fluid cytology
revealed metastatic pancreatic adenocarcinoma—
indicating Stage IV disease with <6 month lifeexpectancy. With this new diagnosis patient was
able to participate in goals of care while
hospitalized and ultimately chose to discharge to
home-hospice care.

Discussion
This case is an excellent illustration of how
sonographic characteristics of pleural
effusion on POCUS can guide the decision
to pursue a diagnostic thoracentesis. Here,
incidental identification of pleural thickening
and fibrinous septations on point of care
ultrasound lead to a diagnostic
thoracentesis which revealed Stage IV
pancreatic adenocarcinoma. This diagnosis
provided the patient with valuable
prognostic information in deciding her
course of care and likely saved her
repeated hospitalization. This case also
emphasizes that patients with clinical
histories suggesting transudative pleural
effusion should still be screened for highrisk sonographic features in order to avoid
missing mixed-etiology pleural effusions.
Figure 1:
Point of care ultrasound demonstrating
an echogenic pleural effusion with
fibrinous septations (blue) and pleural
thickness at 1 cm (orange), prompting
further workup.
Sources
Transudative From Exudative Pleural Effusion.
Chest, 2020. 158(2): p. 692-697.
2. Qureshi, N.R., N.M. Rahman, and F.V.
Gleeson, Thoracic ultrasound in the diagnosis of
malignant pleural effusion. Thorax, 2009. 64(2): p.
139-43.
3. Chian, C.F., et al., Echogenic swirling pattern
as a predictor of malignant pleural effusions in
patients with malignancies. Chest, 2004. 126(1): p.
129-34.
4. Chian, C.F., et al., Echogenic swirling pattern,
carcinoembryonic antigen, and lactate
dehydrogenase in the diagnosis of malignant
pleural effusion. Sci Rep, 2022. 12(1): p. 4077.
5. Asciak, R., et al., Prospective Analysis of the
Predictive Value of Sonographic Pleural Fluid
Echogenicity for the Diagnosis of Exudative
Effusion. Respiration, 2019. 97(5): p. 451-456.

